Cellectis
CLLS
$2.56
Share price
1.59%
Change (1 day)
31.28%
Change (1 year)
Categories
Cellectis (CLLS) - Total assets
Total assets on the balance sheet as of September 2023 : $0.20 B
According to Cellectis's latest financial reports the company's total assets are $0.20 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Cellectis - Total assets on balance sheet (from 2008 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.26 B | -31.63% |
| 2021-12-31 | $0.38 B | -18.62% |
| 2020-12-31 | $0.46 B | 0.43% |
| 2019-12-31 | $0.46 B | -6.66% |
| 2018-12-31 | $0.50 B | 50.46% |
| 2017-12-31 | $0.33 B | 0.44% |
| 2016-12-31 | $0.33 B | -11.12% |
| 2015-12-31 | $0.37 B | 122.83% |
| 2014-12-31 | $0.16 B | 319.69% |
| 2013-12-31 | $39.87 M | -61.08% |
| 2012-12-31 | $0.10 B | -22.32% |
| 2011-12-31 | $0.13 B | 91.66% |
| 2010-12-31 | $68.81 M | -20.17% |
| 2009-12-31 | $86.19 M | 42.08% |
| 2008-12-31 | $60.66 M | 12.61% |
| 2007-12-31 | $53.87 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $33.08 B | 15,675.01% | 🇺🇸 USA |
 uniQure QURE | $0.83 B | 296.61% | 🇳🇱 Netherlands |
 Novavax NVAX | $1.79 B | 757.17% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |